The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
BIOHAVEN LTD COM G1110E107 24,842,849 2,936,507 SH DFND 1, 2 2,936,507 0 0
BIOCRYST PHARMACEUTICALS INC COM 09058V103 36,615,386 3,846,154 SH DFND 1, 2 3,846,154 0 0
CYTOKINETICS, INC COM 23282W605 64,617,637 980,392 SH DFND 1, 2 980,392 0 0
ZENAS BIOPHARMA, INC. COM 98937L105 46,688,333 2,388,150 SH DFND 1, 2 2,388,150 0 0